Get the Stockscreener App
1.35
4.26%
-0.06
After Hours:
1.35
Liminatus Pharma Inc stock is traded at $1.35, with a volume of 649.33K.
It is down -4.26% in the last 24 hours and down -32.33% over the past month.
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
See More
Previous Close:
$1.41
Open:
$1.5
24h Volume:
649.33K
Relative Volume:
0.46
Market Cap:
$35.12M
Revenue:
-
Net Income/Loss:
$-1.40M
P/E Ratio:
-6.5092
EPS:
-0.2074
Net Cash Flow:
$-10.49M
1W Performance:
-14.56%
1M Performance:
-32.33%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.25
$1.50
1-Week Range:
$1.25
$1.6307
52-Week Range:
$1.12
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Name
Liminatus Pharma Inc
Sector
Industry
Phone
213-273-5453
Address
6 CENTERPOINTE DR., LA PALMA
Compare LIMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
1.35 | 38.16M | 0 | -1.40M | -10.49M | -0.2074 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Liminatus Pharma Inc Stock (LIMN) Latest News
What risks investors should watch in Liminatus Pharma Inc. Equity Warrant stockEarnings Growth Report & Safe Capital Growth Plans - newser.com
Will Liminatus Pharma Inc. Equity Warrant stock deliver strong dividend growthPortfolio Gains Report & Safe Entry Zone Identification - newser.com
What makes Liminatus Pharma Inc. stock attractive to growth fundsJuly 2025 Short Interest & Weekly Breakout Opportunity Watchlist - newser.com
Liminatus Pharma Inc. stock trendline breakdownMarket Volume Summary & Real-Time Price Movement Reports - newser.com
Is Liminatus Pharma Inc. Equity Warrant forming a bottoming baseJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Is now a turning point for Liminatus Pharma Inc. Equity WarrantMarket Movement Recap & Expert Approved Momentum Ideas - newser.com
Is Liminatus Pharma Inc. reversing from oversold territory2025 Year in Review & Long-Term Capital Growth Ideas - newser.com
Liminatus Pharma Inc. Equity Warrant stock volume spike explainedEarnings Risk Summary & Smart Swing Trading Alerts - newser.com
Will Liminatus Pharma Inc. stock recover after recent dropJuly 2025 Review & Fast Gaining Stock Reports - newser.com
Pattern recognition hints at Liminatus Pharma Inc. Equity Warrant upsideQuarterly Market Summary & Verified Momentum Stock Alerts - newser.com
Will Liminatus Pharma Inc. see short term momentumBull Run & Technical Entry and Exit Alerts - newser.com
How Liminatus Pharma Inc. stock reacts to Fed rate cutsJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
Can Liminatus Pharma Inc. stock deliver consistent earnings growthJuly 2025 Update & Safe Entry Point Alerts - newser.com
Does Liminatus Pharma Inc. show high probability of rebound2025 Volume Leaders & Technical Confirmation Trade Alerts - newser.com
Will Liminatus Pharma Inc. Equity Warrant stock split attract more investors2025 Major Catalysts & Community Verified Swing Trade Signals - newser.com
Is Liminatus Pharma Inc. Equity Warrant stock resilient to inflationGlobal Markets & Real-Time Stock Entry Alerts - newser.com
Is Liminatus Pharma Inc. stock positioned well for digital economyWeekly Stock Report & Technical Confirmation Trade Alerts - newser.com
What analysts say about Liminatus Pharma Inc stockMarket Profile Overview & Discover Your Financial Freedom Formula - earlytimes.in
Will Liminatus Pharma Inc. benefit from macro trendsPortfolio Value Summary & Intraday High Probability Setup Alerts - newser.com
Custom strategy builders for tracking Liminatus Pharma Inc. Equity WarrantWeekly Stock Report & AI Enhanced Trade Execution Alerts - newser.com
Price momentum metrics for Liminatus Pharma Inc. explained2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
Published on: 2025-10-10 05:53:36 - newser.com
Smart tools for monitoring Liminatus Pharma Inc. Equity Warrant’s price actionJuly 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
Relative strength of Liminatus Pharma Inc. Equity Warrant in sector analysisJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com
Using flow based indicators on Liminatus Pharma Inc.Weekly Trade Summary & Reliable Intraday Trade Plans - newser.com
Historical volatility pattern of Liminatus Pharma Inc. visualizedJuly 2025 Technicals & Community Trade Idea Sharing Platform - newser.com
Is Liminatus Pharma Inc. Equity Warrant stock a bargain at current levels2025 Key Lessons & Low Risk High Win Rate Picks - newser.com
Key metrics from Liminatus Pharma Inc.’s quarterly dataPortfolio Risk Summary & Technical Pattern Alert System - newser.com
Why analysts remain bullish on Liminatus Pharma Inc. Equity Warrant stock2025 Price Momentum & Weekly High Potential Alerts - newser.com
How Liminatus Pharma Inc. Equity Warrant stock performs in weak economyJuly 2025 EndofMonth & Pattern Based Trade Signal System - newser.com
Using data tools to time your Liminatus Pharma Inc. exitJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com
Tools to monitor Liminatus Pharma Inc. recovery probabilityShare Buyback & Growth Focused Stock Reports - newser.com
Liminatus Pharma Inc Stock (LIMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):